Market Size of Gel Documentation Systems Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gel Documentation Systems Market Analysis
The Gel Documentation Systems Market is expected to register a CAGR of 4.10% during the forecast period.
Factors such as the prevalence of infectious diseases and genetic disorders and increasing research investments in genomics and proteomics techniques are boosting the growth of the gel documentation systems market.
With the growing number of cancer cases worldwide, the demand for gel documentation systems for research applications is expected to increase. For instance, according to the report published by the Australia Institute of Health and Welfare, in August 2023, about 162,000 new cancer cases were diagnosed in Australia in 2022, which rose to over 165,000 in 2023. As per the same source, prostate cancer, colorectal cancer, and lung cancer were the most frequently diagnosed cancers. The increase in cancer diagnoses, particularly prostate, colorectal, and lung cancers, is driving the growth of the gel documentation systems market by necessitating advanced tools for accurate molecular and genetic analysis in cancer research and diagnostics.
Additionally, research collaborations are increasing, which is also expected to boost the demand for gel documentation systems. For example, in February 2023, the University of Texas MD Anderson Cancer Center announced a strategic collaboration with biotech company Xilis to accelerate the development of novel cancer therapies using Xilis' proprietary MicroOrganoSphere (MOS) technology. The growing trend of research collaborations is anticipated to significantly enhance the demand for gel documentation systems, driven by the need for advanced technologies in the development of innovative cancer therapies.
Moreover, in January 2022, Eli Lilly and Company acquired exclusive rights to Entos Pharmaceuticals' Fusogenix nucleic acid delivery technology. This acquisition would allow both companies to initiate the research, development, and commercialization of nucleic acid products that target the central and peripheral nervous systems. Eli Lilly will have access to a novel delivery platform technology that can address the challenges of nucleic acid therapeutic modalities, thus contributing to the market's growth. Such developments are expected to increase the demand for research on nucleic acids and proteins, which require gel documentation systems, thus driving the market's growth.
In conclusion, the gel documentation systems market is anticipated to grow over the analysis period due to the increasing prevalence of diseases and research developments. However, the growing adoption of alternative techniques may impede the market's growth.
Gel Documentation Systems Industry Segmentation
As per the scope of the report, the gel documentation system is a gel analysis tool used on digital platforms to monitor and quantify stained agarose gel and acrylamide gels. This device has a comprehensive application for the documentation and imaging of proteins and nucleic acid stained in agarose gels in molecular biology laboratories and clinical research centers.
The gel documentation systems market is segmented by product, detection techniques, light source, application, end user, and geography. The product segment is further segmented into instruments, software, and accessories. The detection techniques are further divided into light-emitting diodes, UV, and laser. The light source segment is further bifurcated into ultraviolet, chemiluminescence, and fluorescence. The application segment is further segmented into nucleic acid quantification, protein quantification, and other applications. The end user segment is further divided into diagnostic labs, pharmaceutical companies, and other end users. The geography segment is further segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD) for the above segments.
| By Products | |
| Instruments | |
| Software | |
| Accessories |
| By Light Source | |
| Light Emmiting Diodes | |
| UV | |
| Laser |
| By Detection Techniques | |
| Ultraviolet | |
| Chemiluminescence | |
| Fluroscence |
| By Application | |
| Nucleic Acid Quantification | |
| Protein Quantification | |
| Other Applications |
| By End User | |
| Diagnostic Labs | |
| Pharamceutical Companies | |
| Other End Users |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Gel Documentation Systems Market Size Summary
The gel documentation systems market is poised for growth, driven by the increasing prevalence of infectious diseases and genetic disorders, alongside rising investments in genomics and proteomics research. The demand for these systems is particularly bolstered by the surge in cancer cases globally, necessitating advanced tools for molecular and genetic analysis in cancer research and diagnostics. Collaborative research efforts, such as those between the University of Texas MD Anderson Cancer Center and Xilis, further amplify the need for gel documentation systems as they develop novel cancer therapies. Additionally, strategic acquisitions, like Eli Lilly's acquisition of Entos Pharmaceuticals' Fusogenix technology, highlight the growing importance of nucleic acid and protein research, which relies on gel documentation systems for accurate analysis. Despite the potential challenges posed by alternative techniques, the market is expected to expand due to these driving factors.
North America is anticipated to experience significant growth in the gel documentation systems market, fueled by the high prevalence of chronic diseases and substantial research investments. The region's advanced healthcare infrastructure supports the demand for these systems in diagnosing and researching target proteins, biomarkers, and nucleic acids. Notable investments in cancer and diabetes research, along with collaborations and funding initiatives, are expected to further propel market growth. Key players such as Bio-Rad Laboratories, Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd, and Merck KGaA are actively contributing to market expansion through product innovations and strategic partnerships. These developments underscore the market's fragmented nature and the potential for continued growth driven by technological advancements and collaborative efforts.
Gel Documentation Systems Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Incidence of Chronic, Infectious Diseases and Genetic Disorders
-
1.2.2 Increasing Research Investment into the Genomic, Proteomics Techniques
-
-
1.3 Market Restraints
-
1.3.1 Growing Adoption of Alternative Techniques
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Products
-
2.1.1 Instruments
-
2.1.2 Software
-
2.1.3 Accessories
-
-
2.2 By Light Source
-
2.2.1 Light Emmiting Diodes
-
2.2.2 UV
-
2.2.3 Laser
-
-
2.3 By Detection Techniques
-
2.3.1 Ultraviolet
-
2.3.2 Chemiluminescence
-
2.3.3 Fluroscence
-
-
2.4 By Application
-
2.4.1 Nucleic Acid Quantification
-
2.4.2 Protein Quantification
-
2.4.3 Other Applications
-
-
2.5 By End User
-
2.5.1 Diagnostic Labs
-
2.5.2 Pharamceutical Companies
-
2.5.3 Other End Users
-
-
2.6 By Geography
-
2.6.1 North America
-
2.6.1.1 United States
-
2.6.1.2 Canada
-
2.6.1.3 Mexico
-
-
2.6.2 Europe
-
2.6.2.1 Germany
-
2.6.2.2 United Kingdom
-
2.6.2.3 France
-
2.6.2.4 Italy
-
2.6.2.5 Spain
-
2.6.2.6 Rest of Europe
-
-
2.6.3 Asia-Pacific
-
2.6.3.1 China
-
2.6.3.2 Japan
-
2.6.3.3 India
-
2.6.3.4 Australia
-
2.6.3.5 South Korea
-
2.6.3.6 Rest of Asia-Pacific
-
-
2.6.4 Middle East and Africa
-
2.6.4.1 GCC
-
2.6.4.2 South Africa
-
2.6.4.3 Rest of Middle East and Africa
-
-
2.6.5 South America
-
2.6.5.1 Brazil
-
2.6.5.2 Argentina
-
2.6.5.3 Rest of South America
-
-
-
Gel Documentation Systems Market Size FAQs
What is the current Gel Documentation Systems Market size?
The Gel Documentation Systems Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)
Who are the key players in Gel Documentation Systems Market?
Bio-Rad Laboratories, Inc., Syngene, Thermo Fisher Scientific, Cleaver Scientific Ltd and Merck KGaA are the major companies operating in the Gel Documentation Systems Market.
